Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 21, 2019; 25(43): 6386-6403
Published online Nov 21, 2019. doi: 10.3748/wjg.v25.i43.6386
Published online Nov 21, 2019. doi: 10.3748/wjg.v25.i43.6386
Figure 6 Dys-regulated genes in SMMC-7721 cells with ubiquitin-conjugating enzyme E2T knockdown.
A: GeneChip assay showed that a total of 630 genes were regulated by ubiquitin-conjugating enzyme E2T (UBE2T) knockdown in SMMC-7721 cells (354 genes were upregulated and 276 genes downregulated) (P < 0.05, fold change > 2); B: The pathway enrichment analysis was performed using IPA software. Orange indicates activated pathways, and blue indicates suppressed pathways; C: Possible regulation network for UBE2T. The map shows upregulated SOD2 and its potential downstream targets. Pink box indicates upregulated genes, and green box indicates downregulated genes; D: qRT-PCR analysis of the indicated genes in ShCtrl and ShUBE2T SMMC-7721 cells. aP < 0.05, bP < 0.01, cP < 0.001; E: ShCtrl and ShUBE2T SMMC-7721 cells were subjected to Western blot analysis.
- Citation: Guo J, Wang M, Wang JP, Wu CX. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis. World J Gastroenterol 2019; 25(43): 6386-6403
- URL: https://www.wjgnet.com/1007-9327/full/v25/i43/6386.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i43.6386